Pathophysiologic Mechanisms of Cardiovascular Disease in Obstructive Sleep Apnea

Sleep Medicine Clinics

Volumn 2, Issue 4, 2007, Pages 539-547

  McNicholas, Walter T ^a,b   Javaheri, Shahrokh ^c  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

^c Sleepcare Diagnostics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; LEPTIN; LIPID;

ADRENERGIC SYSTEM; AROUSAL; ARTERIAL GAS; BLOOD CLOTTING DISORDER; CARDIOVASCULAR DISEASE; DISEASE ASSOCIATION; DISORDERS OF LIPID AND LIPOPROTEIN METABOLISM; ENDOTHELIAL DYSFUNCTION; GLUCOSE INTOLERANCE; HUMAN; HYPERCAPNIA; HYPOCAPNIA; HYPOXEMIA; HYPOXIA; INFLAMMATION; INSULIN RESISTANCE; METABOLIC SYNDROME X; OXIDATIVE STRESS; PATHOPHYSIOLOGY; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; REOXYGENATION; REVIEW; SLEEP APNEA SYNDROME; SYMPATHETIC TONE; THORAX PRESSURE;

EID: 54349110451     PISSN: 1556407X     EISSN: 15564088     Source Type: Journal    
DOI: 10.1016/j.jsmc.2007.08.003     Document Type: Review

References (110)

1. Somers V., and Javaheri S. Cardiovascular effects of sleep-related breathing disorders. In: Kryger M.H., Roth T., and Dement W.C. (Eds). Principles and Practices of Sleep Medicine. 4th edition (2005), WB Saunders, Philadelphia 1180-1191
2. Lavie L. Obstructive sleep apnoea syndrome-an oxidative stress disorder. Sleep Med Rev 7 (2003) 35-51
3. Leuenberger U., Jacob E., Sweer L., et al. Surges of muscle sympathetic nerve activity during obstructive apnea are linked to hypoxemia. J Appl Physiol 79 (1995) 581-588
4. Fletcher E.C., Miller J., Schaaf J.W., et al. Urinary catecholamines before and after tracheostomy in patients with obstructive sleep apnea and hypertension. Sleep 10 1 (1987) 35-44
5. Ziegler M.G., Mills P.J., Loredo J.S., et al. Effect of continuous positive airway pressure and placebo treatment on sympathetic nervous activity in patients with obstructive sleep apnea. Chest 120 3 (2001) 887-893
6. Smith M.L., Niedermaier O.N., Hardy S.M., et al. Role of hypoxemia in sleep apnea-induced sympathoexcitation. J Auton Nerv Syst 56 (1996) 184-190
7. Narkiewicz K., van de Borne P.J., Pesek C.A., et al. Selective potentiation of peripheral chemoreflex sensitivity in obstructive sleep apnea. Circulation 99 (1999) 1183-1189
8. Hedner J., Ejnell H., Sellgren J., et al. Is high and fluctuating muscle nerve sympathetic activity in the sleep apnoea syndrome of pathogenetic importance for the development of hypertension?. J Hypertens Suppl 6 (1988) S529-S531
9. Somers V.K., Dyken M.E., Clary M.P., et al. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 96 (1995) 1897-1904
10. Carlson J.T., Hedner J., Elam M., et al. Augmented resting sympathetic activity in awake patients with obstructive sleep apnea. Chest 103 (1993) 1763-1768
11. Narkiewicz K., Kato M., Phillips B.G., et al. Nocturnal continuous positive airway pressure decreases daytime sympathetic traffic in obstructive sleep apnea. Circulation 100 (1999) 2332-2335
12. Parati G., Di Rienzo M., Bertinieri G., et al. Evaluation of the baroreceptor-heart rate reflex by 24-hour intra-arterial blood pressure monitoring in humans. Hypertension 12 (1988) 214-222
13. Bertinieri G., Di Rienzo M., Cavallazzi A., et al. Evaluation of baroreceptors reflex by blood pressure monitoring in unanesthetized cats. Am J Physiol 254 (1988) H377-H383
14. Parati G., Di Rienzo M., Bonsignore M.R., et al. Autonomic cardiac regulation in obstructive sleep apnea syndrome: evidence from spontaneous baroreflex analysis during sleep. J Hypertens 15 (1997) 1621-1626
15. Bonsignore M.R., Parati G., Insalaco G., et al. CPAP treatment improves baroreflex control of heart rate during sleep in severe OSA. Am J Respir Crit Care Med 166 (2002) 279-286
16. Bonsignore M.R., Parati G., Insalaco G., et al. Baroreflex control of heart rate during sleep in severe obstructive sleep apnoea: effects of acute CPAP. Eur Respir J 27 (2006) 128-135
17. Ryan S., Ward S., Heneghan C., et al. Predictors of decreased spontaneous baroreflex sensitivity in obstructive sleep apnea syndrome. Chest 131 4 (2007) 1100-1107
18. Brooks D., Horner R.L., Kozar L.F., et al. Obstructive sleep apnea as a cause of systemic hypertension. Evidence from a canine model. J Clin Invest 99 (1997) 106-109
19. Fletcher E.C. Physiological consequences of intermittent hypoxia: systemic blood pressure. [invited review]. J Appl Physiol 90 (2001) 1600-1605
20. Fletcher E.C., Bao G., and Li R. Renin activity and blood pressure in response to chronic episodic hypoxia. Hypertension 34 (1999) 309-314
21. Bao G., Metreveli N., Li R., et al. Blood pressure response to chronic episodic hypoxia: role of the sympathetic nervous system. J Appl Physiol 83 (1997) 95-101
22. Willerson J.T., and Ridker P.M. Inflammation as a cardiovascular risk factor. Circulation 109 21 Suppl 1 (2004) II2-II10
23. Glass C.K., and Witztum J.L. Atherosclerosis: the road ahead. Cell 104 4 (2001) 503-516
24. Blake G.J., and Ridker P.M. Inflammatory bio-markers and cardiovascular risk prediction. J Intern Med 252 4 (2002) 283-294
25. Kritchevsky S.B., Cesari M., and Pahor M. Inflammatory markers and cardiovascular health in older adults. Cardiovasc Res 66 2 (2005) 265-275
26. Ghosh S., May M.J., and Kopp E.B. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol 16 (1998) 225-260
27. Skoog T., Dichtl W., Boquist S., et al. Plasma tumour necrosis factor-alpha and early carotid atherosclerosis in healthy middle-aged men. Eur Heart J 23 5 (2002) 376-383
28. Cesari M., Penninx B.W., Newman A.B., et al. Inflammatory markers and onset of cardiovascular events: results from the Health ABC study. Circulation 108 19 (2003) 2317-2322
29. Ridker P.M., Rifai N., Pfeffer M., et al. Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction. Circulation 101 18 (2000) 2149-2153
30. Ciftci T.U., Kokturk O., Bukan N., et al. The relationship between serum cytokine levels with obesity and obstructive sleep apnea syndrome. Cytokine 28 2 (2004) 87-91
31. Dyugovskaya L., Lavie P., and Lavie L. Phenotypic and functional characterization of blood gammadelta T cells in sleep apnea. Am J Respir Crit Care Med 168 2 (2003) 242-249
32. Minoguchi K., Tazaki T., Yokoe T., et al. Elevated production of tumor necrosis factor-alpha by monocytes in patients with obstructive sleep apnea syndrome. Chest 126 5 (2004) 1473-1479
33. Ryan S., Taylor C.T., and McNicholas W.T. Predictors of elevated nuclear factor-kappaB-dependent genes in obstructive sleep apnea syndrome. Am J Respir Crit Care Med 174 7 (2006) 824-830
34. Riha R.L., Brander P., Vennelle M., et al. Tumour necrosis factor-alpha (-308) gene polymorphism in obstructive sleep apnoea-hypopnoea syndrome. Eur Respir J 26 4 (2005) 673-678
35. Ohga E., Tomita T., Wada H., et al. Increased levels of circulating ICAM-1, VCAM-1, and L-selectin in obstructive sleep apnea syndrome. J Appl Physiol 87 (1999) 10-14
36. Blake G.J., and Ridker P.M. C-reactive protein and other inflammatory risk markers in acute coronary syndromes. J Am Coll Cardiol 41 (2003) 37-42
37. Ridker P.M., Hennekens C.H., Buring J.E., et al. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342 (2000) 836-843
38. Ridker P.M., Cushman M., Stampfer M.J., et al. Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation 97 (1998) 425-428
39. Shamsuzzaman A.S., Winnicki M., Lanfranchi P., et al. Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation 105 (2002) 2462-2464
40. Yokoe T., Minoguchi K., Matsuo H., et al. Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation 107 (2003) 1129-1134
41. Tauman R., Ivanenko A., O'Brien L.M., et al. Plasma C-reactive protein levels among children with sleep-disordered breathing. Pediatrics 113 (2004) 564-569
42. Punjabi N.M., and Beamer B.A. C-reactive protein is associated with sleep disordered breathing independent of adiposity. Sleep 30 1 (2007) 29-34
43. Guilleminault C., Kirisoglu C., and Ohayon M.M. C-reactive protein and sleep-disordered breathing. Sleep 27 (2004) 1507-1511
44. Athanasios G., Kaditis A.G., Alexopoulos E.I., et al. Morning levels of C-reactive protein in children with obstructive sleep-disordered breathing. Am J Respir Crit Care Med 171 (2005) 282-286
45. Ryan S., Nolan G., Hannigan E., et al. Cardiovascular risk markers in obstructive sleep apnoea syndrome and correlation with obesity. Thorax 62 6 (2007) 509-514
46. Ryan S., Taylor C.T., and McNicholas W.T. Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome. Circulation 112 17 (2005) 2660-2667
47. Goldbart A., Row B.W., Kheirandish L., et al. Intermittent hypoxic exposure during light phase induces changes in cAMP response element binding protein activity in the rat CA1 hippocampal region: water maze performance correlates. Neuroscience 122 (2003) 585-590
48. Lavie L., Kraiczi H., Hefetz A., et al. Plasma vascular endothelial growth factor in sleep apnea syndrome: effects of nasal continuous positive air pressure treatment. Am J Respir Crit Care Med 165 (2002) 1624-1628
49. Schulz R., Mahmoudi S., Hattar K., et al. Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea. Am J Respir Crit Care Med 162 (2000) 566-570
50. Dyugovskaya L., Lavie P., and Lavie L. Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients. Am J Respir Crit Care Med 165 7 (2002) 934-939
51. Chen L., Einbinder E., Zhang Q., et al. Oxidative stress and left ventricular function with chronic intermittent hypoxia in rats. Am J Respir Crit Care Med 172 (2005) 915-920
52. Xu W., Chi L., Row B.W., et al. Increased oxidative stress is associated with chronic intermittent hypoxia-mediated brain cortical neuronal cell apoptosis in a mouse model of sleep apnea. Neuroscience 126 (2004) 313-323
53. Veasey S.C., Davis C.W., Fenik P., et al. Long-term intermittent hypoxia in mice: protracted hypersomnolence with oxidative injury to sleep-wake brain regions. Sleep 27 (2004) 194-201
54. Zhan G., Serrano F., Fenik P., et al. NADPH oxidase mediates hypersomnolence and brain oxidative injury in a murine model of sleep apnea. Am J Respir Crit Care Med 172 (2005) 921-929
55. Lavie L., Vishnevsky A., and Lavie P. Evidence for lipid peroxidation in obstructive sleep apnea. Sleep 27 (2004) 123-128
56. Carpagnano G.E., Kharitonov S.A., Resta O., et al. 8-Isoprostane, a marker of oxidative stress, is increased in exhaled breath condensate of patients with obstructive sleep apnea after night and is reduced by continuous positive airway pressure therapy. Chest 124 (2003) 1386-1392
57. Schulz R., Seeger W., and Grimminger F. Serum nitrite/nitrate levels in obstructive sleep apnea. Am J Respir Crit Care Med 164 (2001) 1997-1998
58. Zhan G., Fenik P., Pratico D., et al. Inducible nitric oxide synthase in long-term intermittent hypoxia: hypersomnolence and brain injury. Am J Respir Crit Care Med 171 (2005) 1414-1420
59. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 340 (1999) 115-126
60. Vogel R.A. Heads and hearts: the endothelial connection. Circulation 107 (2003) 2766-2768
61. Drager L.F., Bortolotto L.A., Lorenzi M.C., et al. Early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med 172 (2005) 613-618
62. Kraiczi H., Hedner J., Peker Y., et al. Increased vasoconstrictor sensitivity in obstructive sleep apnea. J Appl Physiol 89 (2000) 493-498
63. Kato M., Roberts-Thomson P., Phillips B.G., et al. Impairment of endothelium-dependent vasodilation of resistance vessels in patients with obstructive sleep apnea. Circulation 102 (2000) 2607-2610
64. Ip M.S., Tse H.F., Lam B., et al. Endothelial function in obstructive sleep apnea and response to treatment. Am J Respir Crit Care Med 169 (2004) 348-353
65. Carlson J.T., Rangemark C., and Hedner J.A. Attenuated endothelium-dependent vascular relaxation in patients with sleep apnoea. J Hypertens 14 (1996) 77-84
66. Duchna H.W., Guilleminault C., Stoohs R.A., et al. Vascular reactivity in obstructive sleep apnea syndrome. Am J Respir Crit Care Med 161 (2000) 187-191
67. Ohike Y., Kozaki K., Iijima K., et al. Amelioration of vascular endothelial dysfunction in obstructive sleep apnea syndrome by nasal continuous positive airway pressure-possible involvement of nitric oxide and asymmetric NG, NG-dimethylarginine. Circ J 69 (2005) 221-226
68. Faulx M.D., Larkin E.K., Hoit B.D., et al. Sex influences endothelial function in sleep-disordered breathing. Sleep 27 (2004) 1113-1120
69. Joyner M.J., and Dietz N.M. Nitric oxide and vasodilation in human limbs. J Appl Physiol 83 (1997) 1785-1796
70. Schulz R., Schmidt D., Blum A., et al. Decreased plasma levels of nitric oxide derivatives in obstructive sleep apnoea: response to CPAP therapy. Thorax 55 (2000) 1046-1051
71. Ip M.S., Lam B., Chan L.Y., et al. Circulating nitric oxide is suppressed in obstructive sleep apnea and is reversed by nasal continuous positive airway pressure. Am J Respir Crit Care Med 162 (2000) 2166-2171
72. Agusti A.G., Barbe F., and Togores B. Exhaled nitric oxide in patients with sleep apnea. Sleep 22 (1999) 231-235
73. Haight J.S., and Djupesland P.G. Nitric oxide (NO) and obstructive sleep apnea (OSA). Sleep Breath 7 (2003) 53-62
74. Olopade C.O., Zakkar M., Swedler W.I., et al. Exhaled pentane and nitric oxide levels in patients with obstructive sleep apnea. Chest 111 (1997) 1500-1504
75. Phillips B.G., Narkiewicz K., Pesek C.A., et al. Effects of obstructive sleep apnea on endothelin-1 and blood pressure. J Hypertens 17 (1999) 61-66
76. Grimpen F., Kanne P., Schulz E., et al. Endothelin-1 plasma levels are not elevated in patients with obstructive sleep apnoea. Eur Respir J 15 (2000) 320-325
77. Nieto F.J., Herrington D.M., Redline S., et al. Sleep apnea and markers of vascular endothelial function in a large community sample of older adults. Am J Respir Crit Care Med 169 (2004) 354-360
78. von Kanel R., and Dimsdale J.E. Hemostatic alterations in patients with obstructive sleep apnea and the implications for cardiovascular disease. Chest 124 (2003) 1956-1967
79. Robinson G.V., Pepperell J.C., Segal H.C., et al. Circulating cardiovascular risk factors in obstructive sleep apnoea: data from randomised controlled trials. Thorax 59 (2004) 777-782
80. Shitrit D., Peled N., Shitrit A.B., et al. An association between oxygen desaturation and D-dimer in patients with obstructive sleep apnea syndrome. Thromb Haemost 94 (2005) 544-547
81. Von Kanel R., Loredo J.S., Powell F.L., et al. Short-term isocapnic hypoxia and coagulation activation in patients with sleep apnea. Clin Hemorheol Microcirc 33 (2005) 369-377
82. Steiner S., Jax T., Evers S., et al. Altered blood rheology in obstructive sleep apnea as a mediator of cardiovascular risk. Cardiology 104 (2005) 92-96
83. Kaditis A.G., Alexopoulos E.I., Kalampouka E., et al. Morning levels of fibrinogen in children with sleep-disordered breathing. Eur Respir J 24 (2004) 790-797
84. Shimizu M., Kamio K., Haida M., et al. Platelet activation in patients with obstructive sleep apnea syndrome and effects of nasal-continuous positive airway pressure. Tokai J Exp Clin Med 27 (2002) 107-112
85. Hui D.S., Ko F.W., Fok J.P., et al. The effects of nasal continuous positive airway pressure on platelet activation in obstructive sleep apnea syndrome. Chest 125 (2004) 1768-1775
86. Strohl K.P., Novak R.D., Singer W., et al. Insulin levels, blood pressure and sleep apnea. Sleep 17 7 (1994) 614-618
87. Ip M.S., Lam B., Ng M.M., et al. Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med 165 5 (2002) 670-676
88. Vgontzas A.N., Papanicolaou D.A., Bixler E.O., et al. Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. J Clin Endocrinol Metab 85 3 (2000) 1151-1158
89. Punjabi N.M., Sorkin J.D., Katzel L.I., et al. Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. Am J Respir Crit Care Med 165 5 (2002) 677-682
90. Brooks B., Cistulli P.A., Borkman M., et al. Obstructive sleep apnea in obese noninsulin-dependent diabetic patients: effect of continuous positive airway pressure treatment on insulin responsiveness. J Clin Endocrinol Metab 79 6 (1994) 1681-1685
91. Saarelainen S., Lahtela J., and Kallonen E. Effect of nasal CPAP treatment on insulin sensitivity and plasma leptin. J Sleep Res 6 2 (1997) 146-147
92. Smurra M., Philip P., Taillard J., et al. CPAP treatment does not affect glucose-insulin metabolism in sleep apneic patients. Sleep Med 2 3 (2001) 207-213
93. Harsch I.A., Schahin S.P., Radespiel-Troger M., et al. Continuous positive airway pressure treatment rapidly improves insulin sensitivity in patients with obstructive sleep apnea syndrome. Am J Respir Crit Care Med 169 2 (2004) 156-162
94. Tan K.C., Chow W.S., Lam J.C., et al. Advanced glycation endproducts in nondiabetic patients with obstructive sleep apnea. Sleep 29 (2006) 329-333
95. Oltmanns K.M., Gehring H., Rudolf S., et al. Hypoxia causes glucose intolerance in humans. Am J Respir Crit Care Med 169 (2004) 1231-1237
96. Polotsky V.Y., Li J., Punjabi N.M., et al. Intermittent hypoxia increases insulin resistance in genetically obese mice. J Physiol 552 (2003) 253-264
97. Soderberg S., Ahren B., Jansson J.H., et al. Leptin is associated with increased risk of myocardial infarction. J Intern Med 246 (1999) 409-418
98. Greenberg A.S., and Obin M.S. Obesity and the role of adipose tissue in inflammation and metabolism. [review]. Am J Clin Nutr 83 (2006) 461S-465S
99. O'Donnell C.P., Tankersley C.G., Polotsky V.P., et al. Leptin, obesity, and respiratory function. [review]. Respir Physiol 119 (2000) 163-170
100. Ambrosini G., Nath A.K., Sierra-Honigmann M.R., et al. Transcriptional activation of the human leptin gene in response to hypoxia. J Biol Chem 77 (2002) 34601-34609
101. Shimura R., Tatsumi K., Nakamura A., et al. Fat accumulation, leptin, and hypercapnia in obstructive sleep apnea-hypopnea syndrome. Chest 127 (2005) 543-549
102. Phipps P.R., Starritt E., Caterson I., et al. Association of serum leptin with hypoventilation in human obesity. Thorax 57 (2002) 75-76
103. Barcelo A., Barbe F., Llompart E., et al. Neuropeptide Y and leptin in patients with obstructive sleep apnea syndrome: role of obesity. Am J Respir Crit Care Med 171 (2005) 183-187
104. Tatsumi K., Kasahara Y., Kurosu K., et al. Sleep oxygen desaturation and circulating leptin in obstructive sleep apnea-hypopnea syndrome. Chest 127 (2005) 716-721
105. Patel S.R., Palmer L.J., Larkin E.K., et al. Relationship between obstructive sleep apnea and diurnal leptin rhythms. Sleep 27 (2004) 235-239
106. Sanner B.M., Kollhosser P., Buechner N., et al. Influence of treatment on leptin levels in patients with obstructive sleep apnoea. Eur Respir J 23 (2004) 601-604
107. Harsch I.A., Konturek P.C., Koebnick C., et al. Leptin and ghrelin levels in patients with obstructive sleep apnoea: effect of CPAP treatment. Eur Respir J 22 (2003) 251-257
108. Shimizu K., Chin K., Nakamura T., et al. Plasma leptin levels and cardiac sympathetic function in patients with obstructive sleep apnoea-hypopnoea syndrome. Thorax 57 (2002) 429-434
109. Schafer H., Pauleit D., Sudhop T., et al. Body fat distribution, serum leptin, and cardiovascular risk factors in men with obstructive sleep apnea. Chest 122 (2002) 829-839
110. Ip M.S., Lam K.S., Ho C., et al. Serum leptin and vascular risk factors in obstructive sleep apnea. Chest 118 (2000) 580-586